SpaceX Still Trades Above Its IPO Price. Could Anthropic Do the Same?

Anthropic is reportedly targeting an IPO for the week of Nov. 9, with a debut expected by the end of 2026 even if delayed beyond Thanksgiving. SpaceX priced its IPO at $135 per share, opened public trading at $150, rose to an intraday high of $225.64, and later fell to $104.83; it most recently closed at $171.92. The article says Anthropic's early trading path is uncertain and could be volatile, with no guarantee of a profitable investment.

Analysis

The SpaceX price path is a weak template for Anthropic: launch hype and limited float can dominate early trading, but the two companies have different business models, capital needs, and valuation drivers. The useful signal is not a predicted direction; it is that the IPO price may be a poor proxy for an accessible entry price, and early price discovery can reverse sharply. For Anthropic, the key market mechanism will be whether the S-1 supports AI demand narratives with durable revenue, gross-margin progression, and a credible path to funding compute commitments. Until those are disclosed, enthusiasm can lift the opening print while leaving the stock vulnerable to supply unlocking or disappointing fundamentals.

Near term, avoid extrapolating SpaceX’s recovery to Anthropic or treating SPCX as a clean AI proxy. Over 1–3 months, monitor Anthropic’s registration statement, offering size, allocation/free float, lockup terms, and any customer or infrastructure concentration; these determine whether scarcity or post-listing supply sets the price. Over 6–18 months, compute costs, access to financing, and competitive substitution are more consequential than IPO-day momentum. The contrarian point: “buy the pullback” is not a thesis—without valuation and unit-economics data, a pullback may signal deteriorating fundamentals rather than an entry opportunity. Falsifiers include S-1 evidence of weak monetization or rising funding needs, material lockup-related selling, or sustained post-listing trading below the offer price alongside deteriorating operating metrics.

Key Decisions for Investors

• Do not chase an opening-day move in Anthropic; there is no directly actionable pre-IPO equity trade from the information provided. Reassess only after the S-1 and offering terms are public.
• If seeking exposure after listing, use staged purchases only after price discovery and liquidity normalize; define the thesis around disclosed revenue quality, margins, and compute funding—not a fixed percentage pullback.
• Treat SPCX as an IPO-volatility example, not a directional comparable or AI hedge. Avoid extrapolating its rebound into an Anthropic price target.
• Set a watch alert for offering size, free float, lockup provisions, customer concentration, and compute commitments. If disclosures are unavailable or operating metrics weaken, remain sidelined rather than forcing an IPO trade.